This event will explore policy-driven and market-based approaches to the rising cost of oncology drugs, with an emphasis on demand-side strategies aimed at reshaping prescribing and purchasing behavior.
Speakers will examine incentives, regulatory considerations and innovative payment and delivery models designed to improve affordability while preserving access to high-value cancer care and supporting clinical innovation.
Leave a Reply